TMBR Timber Pharmaceuticals Upside PotentialTMBR Timber Pharmaceuticals had a recent public offering price of $0.64 per share of common stock and accompanying common warrant. The warrants have an exercise price of $0.70 per share.
The price is now 0.47usd
There is a strong upside potential short term!
Price Target 1: $0.85
Price Target 2: $1.37
Stop loss: $0.41
Looking forward to read your opinion about it.
PHARMA
PHABTCLeep ur eyes on PHA.
PHA/BTC tend to bounce from this level
- Falling wedge
- RSI divergence
- 0.618 fib support
if u have patience potential spike towards 0.00001632 sat+
Very risk coin manage your risk pls
Buy Glenmark PharmaceuticalsGlenmark Pharmaceuticals is looking very bullish prior to its earnings.
Daily RSI has formed a huge inverted H&S with a breakout.
Down trendline broken
Price has crossed above 20 and 40 SMA on the daily chart
Three inside up candle pattern formation on the weekly chart
Where next for Merck?Will it break the triangle pattern formed from Dec 2019?
Not easy to tell but I'm thinking of a bullish breakout. Time will tell.
$ZNTL: Oncology MomentumZNTL broke 80 again today and is displaying a strong monthly momentum chart. IBB regaining 160 hopefully will signal at least a moderate health care push that could push ZNTL into the 90s and beyond. Good luck traders!
#DIVISLABAscending triangle pattern breakout coming , RSI around 60 , wait for relative strength for confirmation
DR REDDY - POC assited reversal of polarityOn Thursday, the stock formed Gravestone doji with high volumes.
But on the last day, the bears have been negated since fresh demand has come into place at the POC.
Good price to enter, with stop loss as the red line.
Amarin Corporation: A Hidden GemGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary
Technical analysis
On the chart, we can see the imminent completion of corrective wave 2 and the appearance of impulse wave 3.
Several indicators support the uptrend, including the RSI indicator. In addition, this indicator confirms the Elliott Wave labeling.
On the 1D chart, we can see an open gap in the area of $8.4-12.8 per share.
The company's shares are currently in an uptrend. In addition, Amarin shares are just above the EMA 55 and EMA 89, which also confirms the uptrend.
Fundamental Analysis
You can read a complete fundamental analysis of the company in my analytical article in SA.
Conclusion
Considering the above factors, I believe that the growth of Amarin shares will continue.
Disclosure:
This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
OptiNose: Maximum OptimismGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary:
Technical analysis:
On the chart, we can see the completion of corrective wave 2 and the emergence of impulse wave 3.
According to the RSI indicator, we can see an uptrend, which confirms the labeling of the Elliott waves.
On the 1D chart, we can see an open gap in the area of $6-7 per share.
Currently, the company's shares are in the area of the downtrend breakout. In addition, Optinose shares have broken through EMA 55 and are just below EMA 89.
Fundamental Analysis:
You can read a complete fundamental analysis of the company in my analytical article in SA.
Conclusion
Considering the above factors, I believe that the growth of Optinose shares will continue.
Disclosure:
This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
ADVANCED ENZYMES 15MINADVANCED ENZYMES is making a flag and pole pattern, green lines are the targets and as well as resistance, the pink box is the support.
$XAIR Symmetrical Triangle BreakBeyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
Buy, buy, buy!!!Buy no matter what. I'm in with 40k shares, plan to buy much more for long term ( 5-10 years)
FEMY Femasys Bull PennantOn 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target
On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target
How do you explain such a big difference in valuation?
Where do you see this Bull Pennant heading?
IMVT Immunovant Price TragetsOn 8/13/2021 Chardan Capital brokerage Lowered the Price Target for the Buy rating from $55.00 to $22.00
On 8/10/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $19.00
My price target is the strong 14.5usd resistance.
Short Float 12.76%
52 Week Range 6.68 - 53.75
Now the price is 8.95usd
EDIT Editas medicine ready to break outBeen in this for a little while now since the change in market structure and added a few times to this position so not the best avg weighted entry but still well in profit.
Classic sweep of lows and change in market structure has me excited on this position and more recently over the last month with the gap up above the previous short term high and now the ascending triangle forming showing the bulls still buying up and testing that resistance.
The resistance may be strong but we have had a few cracks at it already and eventually I expect this level to break and to see another descent impulse move.
Bullish on EDIT for now, momentum still on our side.
Auropharma (aurobindo pharma )1. rising wedge pattern formation
2. and inverted flag pattern
3. a clear short opportunity
TORNT PHARMA for short termAs the stock is taking constant support on trend line we can expect a new high ,one can enter above the yellow range only after candle close, the red are the targets and green is SL.
Regeneron - Gaslighting FOMO - Valuation Matters - StonksStonk.
#MSOgang small caps. Investing ain't easy. Rule # whatever, don't be cute. Vaccine play is overplayed.
2021 is not a repeat of '20. A rising rate environment is in works. $GNLN #thegem #cannabisreform
CLEAN SCIENCE LTD 1HRCLEAN SCIENCE LTD 1HR. The lower pink box shows a strong support and the upper red box shows a strong resistance.
Do you have Diamond Hands? Check out NXRP's Volatile Reversal...NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily.
Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug.
High risk with potentially high reward: up to a 25% drawdown and a potential 100+% gain leading to a 4:1 risk to reward ratio. With a ~30% short interest this could be a wild ride like GME or AMC.
Risk management by day trading may be possible.
$DMYD_B falling wedgesDiamyd chart has repeated this descending wedge pattern, followed by breakouts, thrice during the past three months. A fourth inning is in sight, as they are getting ready to head into the phase III clinical trials (labeled "DIAGNODE-3") of their diabetes vaccine "Diamyd".
Vaccine Counter PHARMA Downtrend SignsSupposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast..
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days.
www.straitstimes.com
The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties.
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
